BRAF V600E mutational load as a prognosis biomarker in malignant melanoma

Autor: Javier Rasero, Karmele Mujika, M. Celia Morales, Goikoane Cancho-Galan, P.A. Ezkurra, Ana Sánchez-Diez, Isabel Smith, María Dolores Boyano, Arrate Sevilla, Santos Alonso, Cristina Penas, Verónica Velasco, Aintzane Asumendi, Jesus M. Cortes
Rok vydání: 2019
Předmět:
0301 basic medicine
Oncology
Male
Melanomas
Skin Neoplasms
Biopsy
DNA Mutational Analysis
Artificial Gene Amplification and Extension
Polymerase Chain Reaction
Metastasis
Machine Learning
0302 clinical medicine
Basic Cancer Research
Medicine and Health Sciences
Group-Specific Staining
Medicine
Digital polymerase chain reaction
Neoplasm Metastasis
Melanoma
Aged
80 and over

Staining
Nevus
Pigmented

Multidisciplinary
medicine.diagnostic_test
digital PCR
Middle Aged
Prognosis
030220 oncology & carcinogenesis
Biomarker (medicine)
Female
Research Article
Adult
Proto-Oncogene Proteins B-raf
medicine.medical_specialty
Computer and Information Sciences
Science
Surgical and Invasive Medical Procedures
Research and Analysis Methods
03 medical and health sciences
Diagnostic Medicine
Artificial Intelligence
Internal medicine
Biomarkers
Tumor

Nevus
Humans
Molecular Biology Techniques
neoplasms
Immunohistochemistry Techniques
Molecular Biology
Aged
business.industry
Hematoxylin Staining
Cancers and Neoplasms
Biology and Life Sciences
medicine.disease
digestive system diseases
Histochemistry and Cytochemistry Techniques
030104 developmental biology
Specimen Preparation and Treatment
Cutaneous melanoma
Mutation
Immunologic Techniques
business
V600E
Zdroj: PLoS ONE
Addi. Archivo Digital para la Docencia y la Investigación
instname
Addi: Archivo Digital para la Docencia y la Investigación
Universidad del País Vasco
PLoS ONE, Vol 15, Iss 3, p e0230136 (2020)
ISSN: 1932-6203
Popis: Analyzing the mutational load of driver mutations in melanoma could provide valuable information regarding its progression. We aimed at analyzing the heterogeneity of mutational load of BRAF V600E in biopsies of melanoma patients of different stages, and investigating its potential as a prognosis factor. Mutational load of BRAF V600E was analyzed by digital PCR in 78 biopsies of melanoma patients of different stages and 10 nevi. The BRAF V600E load was compared among biopsies of different stages. Results showed a great variability in the load of V600E (0%-81%). Interestingly, we observed a significant difference in the load of V600E between the early and late melanoma stages, in the sense of an inverse correlation between BRAF V600E mutational load and melanoma progression. In addition, a machine learning approach showed that the mutational load of BRAF V600E could be a good predictor of metastasis in stage II patients. Our results suggest that BRAF V600E is a promising biomarker of prognosis in stage II patients. This research was supported by the Basque Government (grants ELKARTEK-KK2016-036 and KK2017-041 to MDB, grant IT1138-16 to SA and predoctoral fellowship PRE_2014_1_419 to AS), and by the University of the Basque Country (UPV/EHU) (grant GIU17/066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Databáze: OpenAIRE